You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 27, 2024

INVEGA TRINZA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Invega Trinza patents expire, and what generic alternatives are available?

Invega Trinza is a drug marketed by Janssen Pharms and is included in one NDA. There is one patent protecting this drug and three Paragraph IV challenges.

This drug has fifty-two patent family members in twenty-six countries.

The generic ingredient in INVEGA TRINZA is paliperidone palmitate. There are thirty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the paliperidone palmitate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Invega Trinza

A generic version of INVEGA TRINZA was approved as paliperidone palmitate by TEVA PHARMS USA on July 6th, 2021.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for INVEGA TRINZA?
  • What are the global sales for INVEGA TRINZA?
  • What is Average Wholesale Price for INVEGA TRINZA?
Drug patent expirations by year for INVEGA TRINZA
Drug Prices for INVEGA TRINZA

See drug prices for INVEGA TRINZA

Pharmacology for INVEGA TRINZA
Paragraph IV (Patent) Challenges for INVEGA TRINZA
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
INVEGA TRINZA Extended-release Injectable Suspension paliperidone palmitate 273 mg/0.875 mL and 410 mg/1.315 mL 207946 1 2021-07-14
INVEGA TRINZA Extended-release Injectable Suspension paliperidone palmitate 819 mg/2.625 mL 207946 1 2021-04-30
INVEGA TRINZA Extended-release Injectable Suspension paliperidone palmitate 546 mg/1.75 mL 207946 1 2020-06-24

US Patents and Regulatory Information for INVEGA TRINZA

INVEGA TRINZA is protected by two US patents.

Patents protecting INVEGA TRINZA

Dosing regimen for missed doses for long-acting injectable paliperidone esters
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE 4-9 MONTHS AGO

Dosing regimen for missed doses for long-acting injectable paliperidone esters
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE MORE THAN 9 MONTHS AGO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms INVEGA TRINZA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207946-001 May 18, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Janssen Pharms INVEGA TRINZA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207946-004 May 18, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Janssen Pharms INVEGA TRINZA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207946-002 May 18, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for INVEGA TRINZA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms INVEGA TRINZA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207946-004 May 18, 2015 ⤷  Sign Up ⤷  Sign Up
Janssen Pharms INVEGA TRINZA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207946-001 May 18, 2015 ⤷  Sign Up ⤷  Sign Up
Janssen Pharms INVEGA TRINZA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207946-003 May 18, 2015 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for INVEGA TRINZA

When does loss-of-exclusivity occur for INVEGA TRINZA?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Australia

Patent: 16244801
Patent: Dosing regimen for missed doses for long-acting injectable paliperidone esters
Estimated Expiration: ⤷  Sign Up

Patent: 20239611
Patent: Dosing regimen for missed doses for long-acting injectable paliperidone esters
Estimated Expiration: ⤷  Sign Up

Patent: 22221405
Patent: Dosing regimen for missed doses for long-acting injectable paliperidone esters
Estimated Expiration: ⤷  Sign Up

Brazil

Patent: 2017021383
Patent: regime de dosagem para doses omitidas de ésteres de paliperidona injetáveis de longa ação
Estimated Expiration: ⤷  Sign Up

Canada

Patent: 25908
Patent: PROGRAMME DE DOSAGE DE DOSES OUBLIEES DESTINE AUX ESTERS DE PALIPERIDONE INJECTABLES A ACTION PROLONGEE (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷  Sign Up

Patent: 88401
Patent: PROGRAMME DE DOSAGE DE DOSES OUBLIEES DESTINE AUX ESTERS DE PALIPERIDONE INJECTABLES A ACTION PROLONGEE (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷  Sign Up

Croatia

Patent: 0201027
Estimated Expiration: ⤷  Sign Up

Patent: 0240022
Estimated Expiration: ⤷  Sign Up

Cyprus

Patent: 23203
Estimated Expiration: ⤷  Sign Up

Denmark

Patent: 80416
Estimated Expiration: ⤷  Sign Up

Patent: 44326
Estimated Expiration: ⤷  Sign Up

Eurasian Patent Organization

Patent: 7185
Patent: СПОСОБ ЛЕЧЕНИЯ ПСИХОЗА, ШИЗОФРЕНИИ ИЛИ БИПОЛЯРНОГО РАССТРОЙСТВА (METHOD OF TREATING PSYCHOSIS, SCHIZOPHRENIA OR BIPOLAR DISORDER)
Estimated Expiration: ⤷  Sign Up

Patent: 1792209
Patent: СХЕМА ВВЕДЕНИЯ ПРОПУЩЕННЫХ ДОЗ ИНЪЕКЦИОННЫХ СЛОЖНЫХ ЭФИРОВ ПАЛИПЕРИДОНА ДЛИТЕЛЬНОГО ДЕЙСТВИЯ
Estimated Expiration: ⤷  Sign Up

European Patent Office

Patent: 80416
Patent: SCHÉMA DE TRAITEMENT EN CAS DE DOSES OUBLIÉES POUR DES ESTERS DE PALIPÉRIDONE INJECTABLES À ACTION PROLONGÉE (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷  Sign Up

Patent: 44326
Patent: SCHÉMA DE TRAITEMENT EN CAS DE DOSES OUBLIÉES POUR DES ESTERS DE PALIPÉRIDONE INJECTABLES À ACTION PROLONGÉE (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷  Sign Up

Patent: 49323
Patent: SCHÉMA POSOLOGIQUE POUR DOSES MANQUÉES POUR ESTERS DE PALIPÉRIDONE INJECTABLES À ACTION PROLONGÉE (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷  Sign Up

Finland

Patent: 44326
Estimated Expiration: ⤷  Sign Up

Hong Kong

Patent: 49047
Patent: 用於長效可注射的帕利酮酯的遺漏劑量的投藥療程 (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷  Sign Up

Hungary

Patent: 49485
Estimated Expiration: ⤷  Sign Up

Patent: 65435
Estimated Expiration: ⤷  Sign Up

Israel

Patent: 4669
Patent: משטר מינון עבור מינונים חסרים של פליפרידון אסטרים הניתנים להזרקה עם פעילות ארוכת טווח (Dosing regimen for missed doses for long-acting injectable paliperidone esters)
Estimated Expiration: ⤷  Sign Up

Patent: 9340
Patent: משטר מינון עבור מינונים חסרים של פליפרידון אסטרים הניתנים להזרקה עם פעילות ארוכת טווח (Dosing regimen for missed doses for long-acting injectable paliperidone esters)
Estimated Expiration: ⤷  Sign Up

Japan

Patent: 28221
Estimated Expiration: ⤷  Sign Up

Patent: 28503
Estimated Expiration: ⤷  Sign Up

Patent: 22277
Estimated Expiration: ⤷  Sign Up

Patent: 18510894
Patent: 長時間作用型注射可能パリペリドンエステルの抜かした投与量のための投与レジメン
Estimated Expiration: ⤷  Sign Up

Patent: 20090498
Patent: 長時間作用型注射可能パリペリドンエステルの抜かした投与量のための投与レジメン (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷  Sign Up

Patent: 21130680
Patent: 長時間作用型注射可能パリペリドンエステルの抜かした投与量のための投与レジメン (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷  Sign Up

Lithuania

Patent: 80416
Estimated Expiration: ⤷  Sign Up

Patent: 44326
Estimated Expiration: ⤷  Sign Up

Moldova, Republic of

Patent: 80416
Estimated Expiration: ⤷  Sign Up

Patent: 44326
Estimated Expiration: ⤷  Sign Up

Morocco

Patent: 917
Patent: Schéma de traitement en cas de doses oubliées pour des esters de palipéridone injectables à action prolongée
Estimated Expiration: ⤷  Sign Up

Patent: 511
Patent: SCHÉMA DE TRAITEMENT EN CAS DE DOSES OUBLIÉES POUR DES ESTERS DE PALIPÉRIDONE INJECTABLES À ACTION PROLONGÉE
Estimated Expiration: ⤷  Sign Up

New Zealand

Patent: 5952
Patent: Dosing regimen for missed doses for long-acting injectable paliperidone esters
Estimated Expiration: ⤷  Sign Up

Poland

Patent: 80416
Estimated Expiration: ⤷  Sign Up

Patent: 44326
Estimated Expiration: ⤷  Sign Up

Portugal

Patent: 80416
Estimated Expiration: ⤷  Sign Up

Patent: 44326
Estimated Expiration: ⤷  Sign Up

Serbia

Patent: 510
Patent: DOZNI REŽIM ZA PROPUŠTENE DOZE INJEKTIBILNIH ESTARA PALIPERIDONA SA PRODUŽENIM DELOVANJEM (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷  Sign Up

Patent: 024
Patent: DOZNI REŽIM ZA PROPUŠTENE DOZE INJEKTIBILNIH ESTARA PALIPERIDONA SA PRODUŽENIM DELOVANJEM (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷  Sign Up

Slovenia

Patent: 80416
Estimated Expiration: ⤷  Sign Up

Patent: 44326
Estimated Expiration: ⤷  Sign Up

South Korea

Patent: 2606678
Estimated Expiration: ⤷  Sign Up

Patent: 170134583
Patent: 장기간 작용형 주사용 팔리페리돈 에스테르에 대한 누락된 용량에 대한 투여 계획
Estimated Expiration: ⤷  Sign Up

Patent: 230162162
Patent: 장기간 작용형 주사용 팔리페리돈 에스테르에 대한 누락된 용량에 대한 투여 계획 (Dosing regimen for missed doses for long-acting injectable paliperidone esters)
Estimated Expiration: ⤷  Sign Up

Spain

Patent: 02299
Estimated Expiration: ⤷  Sign Up

Patent: 67585
Estimated Expiration: ⤷  Sign Up

Taiwan

Patent: 94825
Estimated Expiration: ⤷  Sign Up

Patent: 1642863
Patent: Dosing regimen for missed doses for long-acting injectable Paliperidone esters
Estimated Expiration: ⤷  Sign Up

Ukraine

Patent: 8732
Patent: СХЕМА ВВЕДЕННЯ ПРОПУЩЕНИХ ДОЗ ЕСТЕРІВ ПАЛІПЕРИДОНУ ТРИВАЛОЇ ДІЇ ДЛЯ ІН'ЄКЦІЙНОГО ЗАСТОСУВАННЯ (DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS)
Estimated Expiration: ⤷  Sign Up

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering INVEGA TRINZA around the world.

Country Patent Number Title Estimated Expiration
Japan 2023552329 持続放出パリペリドン注射可能製剤に関連する投与レジメン ⤷  Sign Up
Slovakia 62098 AQUEOUS SUSPENSIONS OF 9-HYDROXYRISPERIDONE FATTY ACID ESTERS ⤷  Sign Up
Croatia P20240086 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for INVEGA TRINZA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0904081 91842 Luxembourg ⤷  Sign Up 91842, EXPIRES: 20220512
0904081 11C0035 France ⤷  Sign Up PRODUCT NAME: PALMITATE DE PALIPERIDONE; REGISTRATION NO/DATE: EU/1/11/672/001 20110304
0904081 C300491 Netherlands ⤷  Sign Up PRODUCT NAME: PALIPERIDONPALMITAAT; REGISTRATION NO/DATE: EU/1/11/672/001-006 20110304
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.